Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.66 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
Via MarketMinute
Topics Economy Intellectual Property Retirement
Pfizer Declares Fourth-Quarter 2025 Dividend
From Pfizer Inc.
Via Business Wire
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers. 
Via Benzinga
Topics Government
Most active S&P500 stocks in Thursday's session
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
Investors Brace for Pullback as Short-Bias ETF Inflows Signal Growing Bearishness
A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Why Shares in Viking Therapeutics Surged This Week
The small-cap pharmaceutical company may be the next in line as takeover fever heats up. 
Via The Motley Fool
Market Giants Retreat: S&P 500 and Nasdaq Pull Back from Record Highs Amidst Economic Headwinds
The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Wilsey Discloses $2.9 Million Purchase of Pfizer Stock Amid Landmark Trump Deal
Via The Motley Fool
Topics Government Regulatory Compliance
Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing
Via The Motley Fool
Topics Government World Trade
5 Healthcare Plays Powering the Sector’s Big Comeback
After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest. 
Via MarketBeat
Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market
Roche has a promising GLP-1 drug that is entering phase 3 trials. 
Via The Motley Fool
What's going on in today's session: S&P500 most active stocks
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest... 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Why Waters Corporation (WAT) Stock Is Up Today
Shares of scientific instruments company Waters Corporation (NYSE:WAT) jumped 3.2% in the morning session after Rothschild & Co initiated coverage on the stock with a 'Buy' rating and a $390 price... 
Via StockStory
Topics Government
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Carlsbad, CA – October 8, 2025 – Ionis Pharmaceuticals (NASDAQ:IONS) is currently witnessing a remarkable surge in its stock value, nearing a six-year high. This impressive ascent is largely driven by... 
Via MarketMinute
U.S. Government Shutdown Deepens Economic Uncertainty, Airports Face Mounting Strain
Washington D.C., October 8, 2025 – The U.S. federal government remains in the throes of a shutdown, now entering its second week, as lawmakers in Washington continue to grapple with a stalemate over... 
Via MarketMinute
Topics Bonds Economy Government
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
These biotechs could finally come into their own by the end of the decade. 
Via The Motley Fool
Topics Government World Trade
Why AbbVie and Johnson & Johnson Could Outperform Pfizer
Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential 
Via MarketBeat
Eli Lilly Stock Eases After-Hours: Ex-FDA Official Ejected By RFK Jr. Joins Firm — Will Investors Warm Up?
Investors reacted to the company’s leadership shake-up and new data from its ulcerative colitis therapy Omvoh showing sustained remission over four years. 
Via Stocktwits
Topics Government
Curious about the most active S&P500 stocks in today's session?
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
Why QuidelOrtho (QDEL) Stock Is Down Today
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 4.4% in the morning session after Citigroup analyst Patrick Donnelly downgraded the stock to 'Neutral' from 'Buy' and lowered the... 
Via StockStory
Topics World Trade
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
From Brodsky & Smith LLC
Via GlobeNewswire
The No. 1 Investing Mistake to Avoid As Washington Grinds to a Halt
Washington has shut down -- but don't fall into a panic, because these things don't last. 
Via The Motley Fool
Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers
The deal on drug prices between the US Administration and Pfizer will leave the margins of innovative pharma companies intact. 
Via Talk Markets
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows. 
Via The Motley Fool
Topics Intellectual Property
TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy. 
Via MarketBeat
Topics Government
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Tariffs aren't likely to weigh on growth at these companies. 
Via The Motley Fool
Topics Government Stocks World Trade
Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started. 
Via MarketBeat
Topics Government World Trade
Divergent Paths: Real Estate Stumbles While Healthcare Shines Amidst S&P 500's Record Ascent
As the S&P 500 and Nasdaq Composite continue their relentless climb to uncharted record highs in early October 2025, a fascinating and somewhat contradictory narrative is unfolding within the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025.... 
Via MarketMinute
Topics Artificial Intelligence Credit Cards Economy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.